1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. CONTINEUM THERAPEUTICS INC. - ORDINARY SHARES - CLASS A
Contineum Therapeutics Inc. - Ordinary Shares - Class A XNAS: CTNM

Contineum Therapeutics Inc. - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

about

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIP...

Read More
12.50 0.10 (0.81%)
38.42% Fall from 52W High
1.1M
XNAS Volume
High volume today

XNAS 19 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
9.7 / 100
Momentum Score
Technically Moderately Bullish
64.6 / 100
Analyst Price Target
29
1Yr Price target upside is 134%
4 analysts

16

S

4

W

2

O

3

T

SWOT Analysis

Contineum Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..